Tag: Belarus

New pharmaceutical factory in Skidel is expected to launch in October

capsules
New pharmaceutical company in Skidel will produce 6 million tablets and more than 3 million capsules every year, according to Deputy Head of the Health Department of the Regional Authorities.

Russia and Belarus will develop innovative equipment for express diagnostics

lab research
The new complexes will allow doctors to get the results of required tests instantly - even on the operating table or in the office of a paramedic.

New scientific and technological center will be established in Belarus

pills
The scientific and technological center named after Yusuf Hamied will be established based on the state enterprise Akadempharm of the National Academy of Sciences of Belarus.

Borisov Pharmaceutical Plant exports more than 50% of its products

borisov
The Borisov Pharmaceutical Plant (Belarus) produces 280 different medicines, out of them 84 are available on the Russian market, according to Vitaliy Deresh, General Director of the enterprise.

Belarusian drugs are preparing to enter the US market

belarus pills
Belarusian medications are entering new markets. They will be marketed in the US. As for the European Union, one Belarusian plant has already received permission.

Belarus seeks further ways to reduce the cost of drugs

pharmacy
More than 37% of drugs produced in Belarus cost less than $1. Viktor Shein, Deputy Director of the Department of Pharmaceutical Industry, made an announcement.

New scheme for expired drugs utilization is being tested in Minsk

pills
The container intended for collection of spoiled medicines from the community was installed in one of the outpatient clinics in Minsk, being the first one in Belarus.

Belarus will help to organize pharma manufacturing in Tajikistan

pharma-manufacturing
By the end of this year, Belarus and Tajikistan may elaborate a roadmap to establish joint ventures in the pharmaceutical industry, announced Oleg Ivanov, the Ambassador of Belarus in Tajikistan and Afghanistan.

New pharma plant in Belarus to launch in October

pharma manufacturing
A pharmaceutical plant in Skidel (Belarus) will be launched in October, announced the press service of the Council of Republic following the meeting between curator of the Belarusian-Indian cooperation and Indian investors

Registration of prices for medicines in Belarus will take no more than 1-2 months

manufacturing
This was announced by the Deputy Head of Department for Social Sphere and Services of the Belarusian Ministry of Antimonopoly Regulation and Trade - Daria Orlova.

Belarus developed the technology of obtaining povidone iodine

belaseptika
Belarus developed a technology for obtaining a pharmaceutical substance that can be used for manufacturing iodine-based medicines, announced Maria Sekach, Commercial Director of Belaseptika CJSC.

Belarusian pharmaceutical products will strengthen their positions in Tajikistan

belarus pills
Belarus plans to double the sales of its medicines in the market of Tajikistan. This was announced by the Minister of Health of Belarus Valery Malashko.

Belarus will reduce the period of bioequivalence studies

lab
Now that the specialists and necessary equipment are located at the same site, the time to obtain the final report will be significantly reduced.

Belarus considers introduction of reference pricing for medicines

drugs
Belarus is planning to introduce a reference pricing system for medicines, said Vladimir Koltovich, Minister of Antimonopoly Regulation and Trade.

Belarus plans the market launch of 40 new drugs by 2020

belarus pills
Nearly 40 new drugs will be launched by the end of 2020 as a part of the State Program for Pharmaceutical Industry Development. This was announced by the Chairman of the State Committee on Science and Technology.

NatiVita plans to set up R&D centers in Belarus and Saint Petersburg

test tubes
Plans have been made to set up centers for developing personified vaccines in Belarus and Saint Petersburg, according to Aleksei Sychev, Chairman of the Board of Directors of the Belarusian pharmaceutical company NatiVita.